News
Pharmaceutical Technology on MSN1d
Biogen’s Friedreich’s ataxia treatment authorised in UKFriedreich's ataxia is a widespread hereditary ataxia type, affecting a minimum of one in every 50,000 individuals. It is c ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback